BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression

Kumaran Mudaliar, Michael T. Tetzlaff, Madeleine Duvic, Ana Ciurea, Sharon Hymes, Denái R. Milton, Kenneth Y. Tsai, Victor G. Prieto, Carlos A. Torres-Cabala, Jonathan L. Curry

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression'. Together they form a unique fingerprint.

Medicine & Life Sciences